Blood test for long COVID diagnosis
Part of Infections, Lungs & breathing clinical trials.
This study is testing a new blood test that looks for specific RNA markers to help diagnose long COVID. If you have new, lasting symptoms after a confirmed COVID-19 infection, this study may help find answers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have had a confirmed COVID-19 infection, either by a lab test or a positive rapid test at home.
- To be in the long COVID group, you need to have new health problems that started after your COVID-19 infection and are still going on.
- Your ongoing symptoms must be related to COVID-19, not another medical condition.
- You must be able to understand and sign a consent form to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new, non-invasive way to diagnose Long COVID using a simple bioelectrical assessment. It might help if you've had COVID-19 and have been dealing with ongoing symptoms for 12 weeks or longer.
This study looks for signs of Long COVID in the blood and gut to better understand the condition. If you have Long COVID or were exposed to the virus without developing it, you may be able to help.
This study looks at how cells make energy in people with Long COVID compared to people who fully recovered. It involves a blood draw, a small muscle sample, and a skin biopsy to understand why symptoms last.
This study looks at how COVID-19 affects people in the long term. It aims to understand the lasting symptoms (often called long COVID) and how they impact your daily life. You may join if you have ongoing symptoms after COVID-19 that bother you or reduce your quality of life.
This study looks at certain molecules (called microRNAs) and vitamin B12 levels in people who have ongoing brain-related symptoms like depression, anxiety, or fatigue after a COVID-19 infection. It may help understand why some people have long-lasting symptoms and could lead to better treatments.
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.